# A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin

> **NCT00175032** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 1045 (actual)

## Conditions studied

- Osteoarthritis
- Peptic Ulcer

## Interventions

- **DRUG:** Lansoprazole and naproxen and aspirin
- **DRUG:** Celecoxib and aspirin

## Key facts

- **NCT ID:** NCT00175032
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 1045 (ACTUAL)
- **Last updated:** 2010-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00175032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00175032, "A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00175032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*